{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:11:48Z","timestamp":1771373508388,"version":"3.50.1"},"reference-count":68,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IRCCS \u201cCentro Neurolesi Bonino-Pulejo\u201d, Messina, Italy","award":["current research funds 2019"],"award-info":[{"award-number":["current research funds 2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>We evaluated the in silico expression and circulating levels of interleukin (IL)37 in patients with different forms of multiple sclerosis (MS) and also upon treatment with different disease-modifying drugs. The combined interpretation of the resulting data strengthens and extends the current emerging concept that endogenous IL37 plays an important role in determining onset and progression of MS. The in silico analysis revealed that production of IL37 from cluster of differentiation (CD)4+ T cells from MS patients was reduced in vitro as compared to healthy controls. The analysis of the datasets also demonstrated that \u201chigher\u201d levels of IL37 production from PBMC entailed significant protection from MS relapses. In addition, the in vivo part of the study showed that IL37 was selectively augmented in the sera of MS patients during a relapse and that treatment with the high potency disease-modifying drug fingolimod significantly increased the frequency of patients with circulating blood levels of IL37 (6\/9, 66%) as compared to patients receiving no treatment (n = 48) or platform therapy (n = 59) who had levels of IL37 below the limit of the sensitivity of the assay. This finding therefore anticipates that fingolimod may at least partially exert its beneficial effects in MS by upregulating the production of IL37.<\/jats:p>","DOI":"10.3390\/molecules25010020","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T03:23:12Z","timestamp":1577071392000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod"],"prefix":"10.3390","volume":"25","author":[{"given":"Eugenio","family":"Cavalli","sequence":"first","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-4694","authenticated-orcid":false,"given":"Maria Sofia","family":"Basile","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santa","family":"Mammana","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Pennisi","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-1992","authenticated-orcid":false,"given":"Paolo","family":"Fagone","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reni","family":"Kalfin","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Block 23 1113 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Martinovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Ivanovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Andabaka","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarlota","family":"Mesaros","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-1409","authenticated-orcid":false,"given":"Tatjana","family":"Pekmezovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-8462","authenticated-orcid":false,"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Petralia","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mammana, S., Fagone, P., Cavalli, E., Basile, M., Petralia, M., Nicoletti, F., Bramanti, P., and Mazzon, E. (2018). The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer\u2019s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030831"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2018.06.009","article-title":"Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences","volume":"322","author":"Fagone","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E8421","DOI":"10.1073\/pnas.1712288114","article-title":"MIF and D-DT are potential disease severity modifiers in male MS subjects","volume":"114","author":"Benedek","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(96)00101-4","article-title":"Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis","volume":"70","author":"Nicoletti","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI3125","article-title":"Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy","volume":"102","author":"Comabella","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.57.2.342","article-title":"Increased serum levels of interleukin-18 in patients with multiple sclerosis","volume":"57","author":"Nicoletti","year":"2001","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clineuro.2016.04.027","article-title":"The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis","volume":"146","author":"Orhan","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/cyto.1996.0054","article-title":"Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment","volume":"8","author":"Nicoletti","year":"1996","journal-title":"Cytokine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","article-title":"The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy","volume":"207","author":"Dujmovic","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2249.1998.00604.x","article-title":"Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)","volume":"113","author":"Nicoletti","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2016.06.005","article-title":"Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis","volume":"300","author":"Valenzuela","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00365513.2017.1303843","article-title":"Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis","volume":"77","author":"Trenova","year":"2017","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjms.2018.08.018","article-title":"The properties of cytokines in multiple sclerosis: Pros and cons","volume":"356","author":"Wang","year":"2018","journal-title":"Am. J. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Quirk, S., and Agrawal, D.K. (2014). Immunobiology of IL-37: Mechanism of action and clinical perspectives. Expert Rev. Clin. Immunol.","DOI":"10.1586\/1744666X.2014.971014"},{"key":"ref_17","first-page":"4711","article-title":"Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_18","first-page":"165","article-title":"Role of interleukin-37 in inflammatory and autoimmune diseases","volume":"15","author":"Wang","year":"2018","journal-title":"Iran. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Lo","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P., and Dinarello, C.A. (2010). IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol.","DOI":"10.1038\/ni.1944"},{"key":"ref_21","unstructured":"Nold, M.F., Bulau, A.-M., Rubartelli, A., Bufler, P., Nold-Petry, C.A., Fink, M., Li, S., Dinarello, C.A., Hong, J., and Mansell, A. (2014). Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc. Natl. Acad. Sci. USA."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Xie, Y., Li, Y., Cai, X., Wang, X., and Li, J. (2016). Interleukin-37 suppresses ICAM-1 expression in parallel with NF-\u03baB down-regulation following TLR2 activation of human coronary artery endothelial cells. Int. Immunopharmacol.","DOI":"10.1016\/j.intimp.2016.05.003"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","article-title":"IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17\u2013triggering cytokine production and limiting th17 cell proliferation","volume":"194","author":"Ye","year":"2015","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","article-title":"Insights into IL-37, the role in autoimmune diseases","volume":"14","author":"Xu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.intimp.2019.01.037","article-title":"IL-37 suppresses the sustained hepatic IFN-\u03b3\/TNF-\u03b1 production and T cell-dependent liver injury","volume":"69","author":"Feng","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, B., Huang, K., Ye, L., Li, Y., Zhang, J., Zhang, J., Fan, X., Liu, X., Li, L., and Sun, J. (2015). Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J. Transl. Med., 13.","DOI":"10.1186\/s12967-015-0394-3"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, Y., Wang, Z., Yu, T., Chen, B., Zhang, J., Huang, K., and Huang, Z. (2014). Increased expression of IL-37 in patients with Graves\u2019 disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107183"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1159\/000489074","article-title":"Comparison of concanavalin a-induced murine autoimmune hepatitis models","volume":"46","author":"Ye","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1043-4666(03)00103-0","article-title":"Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis","volume":"22","author":"Kaneko","year":"2003","journal-title":"Cytokine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diab.47.1.32","article-title":"Paradoxical antidiabetogenic effect of \u03b3-interferon in DP-BB rats","volume":"47","author":"Nicoletti","year":"1998","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s13760-015-0491-3","article-title":"Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica","volume":"115","author":"Farrokhi","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"ref_34","first-page":"329","article-title":"Correlation of serum levels of IL-33, IL-37, soluble form of vascular endothelial growth factor receptor 2 (vegfr2), and circulatory frequency of VEGFR2-expressing cells with multiple sclerosis severity","volume":"16","author":"Kouchaki","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1096\/fj.201700524R","article-title":"Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: A key role of IL-37","volume":"31","author":"Giacoppo","year":"2017","journal-title":"Faseb J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3389\/fimmu.2018.01240","article-title":"Profiling of canonical and non-traditional cytokine levels in interferon-\u03b2-treated relapsing-remitting-multiple sclerosis patients","volume":"9","author":"Reale","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.autrev.2017.02.007","article-title":"Multiple sclerosis in the real world: A systematic review of fingolimod as a case study","volume":"16","author":"Ziemssen","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lombardo, S.D., Mazzon, E., Basile, M.S., Cavalli, E., Bramanti, P., Nania, R., Fagone, P., Nicoletti, F., and Petralia, M.C. (2019). Upregulation of IL-1 receptor antagonist in a mouse model of migraine. Brain Sci., 9.","DOI":"10.3390\/brainsci9070172"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mazzon, E., Basile, M.S., Mangano, K., Di Marco, R., Bramanti, P., Nicoletti, F., Fagone, P., and Petralia, M.C. (2019). Upregulated expression of macrophage migration inhibitory factor, its analogue D-dopachrome tautomerase, and the CD44 receptor in peripheral CD4 T cells from clinically isolated syndrome patients with rapid conversion to clinical defined multiple sclerosis. Medicina (B. Aires), 55.","DOI":"10.3390\/medicina55100667"},{"key":"ref_40","first-page":"2055","article-title":"Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression","volume":"18","author":"Petralia","year":"2019","journal-title":"Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lombardo, S.D., Mazzon, E., Basile, M.S., Campo, G., Corsico, F., Presti, M., Bramanti, P., Mangano, K., Petralia, M.C., and Nicoletti, F. (2019). Modulation of Tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184323"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jneuroim.2019.05.006","article-title":"Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF","volume":"332","author":"Nicoletti","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fagone, P., Mazzon, E., Mammana, S., Di Marco, R., Spinasanta, F., Basile, M., Petralia, M., Bramanti, P., Nicoletti, F., and Mangano, K. (2019). Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment. Mol. Med. Rep.","DOI":"10.3892\/mmr.2019.10283"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/jcp.26223","article-title":"Involvement of the Nrf2\/HO-1\/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis","volume":"233","author":"Mangano","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"44564","DOI":"10.1038\/srep44564","article-title":"Identification of novel chemotherapeutic strategies for metastatic uveal melanoma","volume":"7","author":"Fagone","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Petralia, M.C., Mazzon, E., Fagone, P., Russo, A., Longo, A., Avitabile, T., Nicoletti, F., Reibaldi, M., and Basile, M.S. (2019). Characterization of the pathophysiological role of CD47 in uveal melanoma. Molecules, 24.","DOI":"10.3390\/molecules24132450"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Basile, M.S., Fagone, P., Mangano, K., Mammana, S., Magro, G., Salvatorelli, L., Li Destri, G., La Greca, G., Nicoletti, F., and Puleo, S. (2019). KCNMA1 Expression is downregulated in colorectal cancer via epigenetic mechanisms. Cancers, 11.","DOI":"10.3390\/cancers11020245"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Basile, M.S., Mazzon, E., Russo, A., Mammana, S., Longo, A., Bonfiglio, V., Fallico, M., Caltabiano, R., Fagone, P., and Nicoletti, F. (2019). Differential modulation and prognostic values of immune-escape genes in uveal melanoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210276"},{"key":"ref_49","first-page":"911","article-title":"The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer\u2019s disease","volume":"42","author":"Candido","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mazzon, E., Mammana, S., Basile, M.S., Lombardo, S.D., Mangano, K., Bramanti, P., Nicoletti, F., Fagone, P., and Petralia, M.C. (2019). Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma. Brain Sci., 9.","DOI":"10.3390\/brainsci9100284"},{"key":"ref_51","first-page":"2881","article-title":"Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma","volume":"16","author":"Presti","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lombardo, S.D., Presti, M., Mangano, K., Petralia, M.C., Basile, M.S., Libra, M., Candido, S., Fagone, P., Mazzon, E., and Nicoletti, F. (2019). Prediction of PD-L1 expression in neuroblastoma via computational modeling. Brain Sci., 9.","DOI":"10.3390\/brainsci9090221"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mangano, K., Mazzon, E., Basile, M.S., Di Marco, R., Bramanti, P., Mammana, S., Petralia, M.C., Fagone, P., and Nicoletti, F. (2018). Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. Oncotarget, 9.","DOI":"10.18632\/oncotarget.24885"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lazarevi\u0107, M., Mazzon, E., Mom\u010dilovi\u0107, M., Basile, M.S., Colletti, G., Petralia, M.C., Bramanti, P., Nicoletti, F., and Miljkovi\u0107, \u0110. (2018). The H\u2082S donor GYY4137 stimulates reactive oxygen species generation in BV2 cells while suppressing the secretion of TNF and nitric oxide. Molecules, 23.","DOI":"10.3390\/molecules23112966"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.4049\/jimmunol.161.4.1989","article-title":"IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia","volume":"161","author":"Liu","year":"1998","journal-title":"J. Immunol."},{"key":"ref_57","first-page":"2055217318778610","article-title":"Relapse rate and MRI activity in young adult patients with multiple sclerosis: A post hoc analysis of phase 3 fingolimod trials","volume":"4","author":"Chitnis","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"577065","DOI":"10.1016\/j.jneuroim.2019.577065","article-title":"Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients","volume":"337","author":"Altunrende","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Dinarello, C. (1996). Biologic basis for interleukin-1 in disease. Blood, 87.","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1016\/j.celrep.2016.08.036","article-title":"Dynamic response genes in CD4+ T cells reveal a network of interactive proteins that classifies disease activity in multiple sclerosis","volume":"16","author":"Hellberg","year":"2016","journal-title":"Cell Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2119\/molmed.2010.00071","article-title":"Gene expression changes in multiple sclerosis relapse suggest activation of T and Non-T cells","volume":"17","author":"Lindsey","year":"2011","journal-title":"Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awq354","article-title":"CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis","volume":"134","author":"Annibali","year":"2011","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gurevich, M., Tuller, T., Rubinstein, U., Or-Bach, R., and Achiron, A. (2009). Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med. Genom., 2.","DOI":"10.1186\/1755-8794-2-46"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.msard.2019.01.008","article-title":"2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity?","volume":"29","author":"Gobbin","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1191\/1352458504ms1018xx","article-title":"The MS co-operative research (MS-CORE) group: An alternate approach to fostering multicenter studies","volume":"10","author":"Cohen","year":"2004","journal-title":"Mult. Scler."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: Using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.25463","article-title":"Silent progression in disease activity\u2013free relapsing multiple sclerosis","volume":"85","author":"Cree","year":"2019","journal-title":"Ann. Neurol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:43:42Z","timestamp":1760190222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["molecules25010020"],"URL":"https:\/\/doi.org\/10.3390\/molecules25010020","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]}}}